Aug 2026· Virology· Vol 624, pp.
111056
· 0 citations· 68 references
Medicine
TL;DR
The results indicate that the IP is a protective host factor during acute MHV-1 infection, confirming previous findings with IP inhibition, and suggest that the IP is dispensable for the development of adaptive immune responses and protective immunity to MHV-1.
Abstract
The immunoproteasome (IP) is a component of cellular proteasome machinery that is predominantly inducible by IFN-γ. IP activity contributes to multiple aspects of immune function, inflammation, and protein homeostasis. IP subunit expression increases during respiratory infection with murine hepatitis virus strain 1 (MHV-1), a mouse coronavirus, and pharmacologic inhibition increased virus-induced inflammation and mortality. In this study, we used mice that are completely deficient in IP activity to evaluate effects of IP deficiency, instead of IP inhibition, on MHV-1 pathogenesis. IP deficiency had no effect on viral replication in lungs or livers in mice infected with a low dose, but viral replication was greater in livers of mice infected with a high dose. IP deficiency altered expression of IFN-γ and other cytokines in an organ- and virus dose-dependent manner. MHV-1 infection increased expression of genes associated with endoplasmic reticulum stress response, but there were minimal differences between IP-deficient and wild type mice. IP deficiency tended to decrease the amount of total virus-specific IgG. However, neutralizing antibody and protective immunity to repeat MHV-1 infection was intact in IP-deficient mice. Our results indicate that the IP is a protective host factor during acute MHV-1 infection, confirming our previous findings with IP inhibition. However, the results suggest that the IP is dispensable for the development of adaptive immune responses and protective immunity to MHV-1.
It is demonstrated that Irf7 protects against severe IAV pathogenesis independently of Tlr7 recognition in mice, whereas both Irf7 and Tlr7 are required for optimal anti-HA antibody production.
Ana Karina Nisperuza Vidal, Chen-Xiao Wang, Michaela J. Allen et al.· Viruses· 0 citations
It is demonstrated that a rational combination of pharmacological targeting of innate and adaptive immune responses is sufficient to reduce mortality and severe illness caused by beta, delta and EG.1 variants in SARS-CoV-2 infection.
Ming Zhou, Xuan Liu, Haiqing Xiao et al.· Molecular Therapy· 0 citations
It is found that the amount of virus macrophages are exposed to determines the likelihood of survival versus an inflammatory death mediated by integrated programmed cell death mechanisms, which can be inhibited by Necrostatin-1, a promising treatment for multiple inflammatory diseases.
Gabrielle Vragel, Gracyn Nelson-Reid, Rachael E. Kostelecky et al.· bioRxiv· 0 citations
RNA viruses, major pathogens of humans and animals, are responsible for numerous inflammatory diseases. Commonly, mild RNA virus infection fails to trigger inflammatory diseases due to host immune homeostasis. However, severe RNA virus infection destroys immune homeostasis and causes hyperinflammation. The detail mecha...
Qiang-Hui Liu, Peiran Chen, Chun-Yan He et al.· Proceedings of the National...· 0 citations
It is suggested that M1 and prolonged IL-4 polarized Mϕ exhibit distinct molecular profiles that may be associated with the observed diminished LCMV infection.
Andra Banete, Julia Barilo, M. Rauh et al.· Cytokine· 0 citations
Cytomegalovirus (CMV)-induced pneumonia is associated with excessive pulmonary inflammation and severe lung injury, particularly in immunocompromised individuals. Effective therapeutic strategies targeting both viral replication and inflammation-driven lung damage remain limited. Quercetin, a naturally occurring flavon...
Ping Sun, Xin-Xiang Chen, Xiao-Juan Wang et al.· Microbial Pathogenesis· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.